- Home
- PBFS vs CERS Comparison
PBFS vs CERS Comparison
Compare PBFS & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBFS
- CERS
- Stock Information
- Founded
- PBFS 1889
- CERS 1991
- Country
- PBFS United States
- CERS United States
- Employees
- PBFS N/A
- CERS N/A
- Industry
- PBFS Banks
- CERS EDP Services
- Sector
- PBFS Finance
- CERS Technology
- Exchange
- PBFS Nasdaq
- CERS Nasdaq
- Market Cap
- PBFS 309.6M
- CERS 347.3M
- IPO Year
- PBFS N/A
- CERS 1997
- Fundamental
- Price
- PBFS $11.75
- CERS $1.65
- Analyst Decision
- PBFS
- CERS Buy
- Analyst Count
- PBFS 0
- CERS 3
- Target Price
- PBFS N/A
- CERS $3.17
- AVG Volume (30 Days)
- PBFS 20.9K
- CERS 1.6M
- Earning Date
- PBFS 01-30-2025
- CERS 02-20-2025
- Dividend Yield
- PBFS N/A
- CERS N/A
- EPS Growth
- PBFS 6.93
- CERS N/A
- EPS
- PBFS 0.73
- CERS N/A
- Revenue
- PBFS $79,730,000.00
- CERS $180,270,000.00
- Revenue This Year
- PBFS N/A
- CERS $15.95
- Revenue Next Year
- PBFS N/A
- CERS $10.50
- P/E Ratio
- PBFS $16.16
- CERS N/A
- Revenue Growth
- PBFS 10.09
- CERS 15.29
- 52 Week Low
- PBFS $8.76
- CERS $1.38
- 52 Week High
- PBFS $12.05
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- PBFS 54.69
- CERS 41.40
- Support Level
- PBFS $11.65
- CERS $1.64
- Resistance Level
- PBFS $12.05
- CERS $1.96
- Average True Range (ATR)
- PBFS 0.25
- CERS 0.11
- MACD
- PBFS 0.02
- CERS -0.02
- Stochastic Oscillator
- PBFS 62.96
- CERS 3.12
About PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.